<DOC>
	<DOC>NCT01282606</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety of SI-6603 in lumbar disc herniation patients.</brief_summary>
	<brief_title>Clinical Trial to Assess Safety of SI-6603 in Patients With Lumbar Disc Herniation</brief_title>
	<detailed_description />
	<mesh_term>Hernia</mesh_term>
	<mesh_term>Intervertebral Disc Displacement</mesh_term>
	<criteria>Patients with lumbar disc herniation (L4L5 or L5S1) as assessed by MRI and clinical symptoms corresponding to position of the impaired nerve root. Patients assessed as positive in the SLR test. Patients with sciatica in either lower leg. Patients with no improvement from pharmacotherapy or concomitant treatment with drug and nerve block. Patients who have 2 or more lumbar disc herniations as assessed by MRI. Patients with "extrusiontype" or "sequestrationtype" herniation in whom a rupture into the posterior longitudinal ligament is identified by MRI. Patients who have received nerve block within 3 weeks before screening. Patients who have undergone lumbar operation, chemonucleolysis, or percutaneous nucleotomy.</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Chemonucleolysis</keyword>
	<keyword>Lumbar Vertebrae</keyword>
	<keyword>Hernia</keyword>
</DOC>